{
    "nct_id": "NCT03078855",
    "official_title": "ILyAD (Indolent Lymphoma And Vitamin D) A Phase III Double Blind, Randomized Trial to Evaluate the Effect of Vitamin D on Progression-free Survival in Patients With Low Tumor-burden Indolent Non-Hodgkin Lymphoma Treated With Rituximab",
    "inclusion_criteria": "Each of the following criteria must be met in order for a patient to be considered eligible for registration:\n\n* Biopsy proven (with hematopathology review at one of the participating sites to confirm correct histology in accordance with World Health Organization) indolent lymphoma to include the following diagnoses:\n\n  * Grade 1, 2, or 3a follicular lymphoma\n  * Small lymphocytic lymphoma (CLL excluded)\n  * Marginal zone lymphoma (nodal or splenic)\n  * Mucosal-associated lymphoid tissue\n* Measurable disease defined by Lugano criteria\n* No prior anti-lymphoma systemic therapy; prior radiation therapy allowed\n* Age 18 or over\n* Ann Arbor stages II, III or IV\n* Patients with follicular lymphoma must have PET FDG-avid lymphoma and fulfill Low tumor burden by Groupe D'Etude des Lymphomes Folliculaires (GELF) criteria:\n\n  * No mass > 7 cm\n  * < 3 distinct masses of greater than 3 cm\n  * No B symptoms\n  * No splenomegaly > 16 cm by computed tomography (CT) scan\n  * No risk of vital organ compression\n  * No leukemic phase > 5000/µl circulating lymphocytes (except for in patients with splenic marginal zone diagnosis)\n  * No cytopenias (platelets < 100,000/µl, hemoglobin < 10 g/dl, or absolute neutrophil count < 1500/µl)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "The following criteria will prevent inclusion of an inappropriate subject into the trial:\n\n* Osteoporosis requiring prescription treatment\n* Known symptomatic primary hyperparathyroidism\n* Hypercalcemia defined as above the institutional normal range (corrected for albumin when albumin levels are below normal)\n* History of calcium-related kidney stones\n* Creatinine > 1.5X above upper limit of normal\n* Women who are known to be pregnant or who plan to become pregnant while on rituximab treatment",
    "miscellaneous_criteria": ""
}